Monoclonal Mouse anti‑Cryptosporidium Immunodominant Antigen Cp23 Antibody (clone BU‑33, WB)

Monoclonal Mouse anti‑Cryptosporidium Immunodominant Antigen Cp23 Antibody (clone BU‑33, WB) (CAT#: PAK-180)

Product Type
Monoclonal antibody
Antibody
Cryptosporidium Immunodominant Antigen Cp23 Mouse anti-Cryptosporidium Monoclonal (BU-33) Antibody
Format
Unconjugated, unmodified
Description
This is an unconjugated mouse monoclonal antibody to Cryptosporidium Immunodominant Antigen Cp23. Validated for ELISA and WB. Cited in 1 publication.
Target
Cryptosporidium immunodominant antigen Cp23
Host
Mouse
Reactivity
Cryptosporidium (tested or 100% immunogen sequence identity)
Clonality
IgG2b Monoclonal
Clone
BU-33
Conjugations
Unconjugated
Purification
Affinity purified
Modifications
Unmodified
Immunogen
Recombinant protein corresponding to full length Immunodominant antigen Cp23.
Specificity
Anti-Immunodominant antigen Cp23 recognizes recombinant protein Immunodominant antigen Cp23.
Applications
WB, ELISA
Presentation
Citrate-Tris-HCl buffer, pH 7.0, 0.02% proclin 300.
Storage
Store at -20°C for up to 1 year.
Restrictions
For research use only. Intended for use by laboratory professionals.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.

Contact Info
Inquiry
Copyright © Ace Therapeutics. All Rights Reserved.
Top